The latest announcement is out from bioAffinity Technologies, Inc. (BIAF).
Michael Dougherty has decided to step down as the Chief Financial Officer of bioAffinity Technologies to explore new opportunities and will assist in a smooth transition until September 16, 2024. His departure is not due to any disputes over the company’s operations or financial practices. Succeeding him is Michael Edwards, a seasoned finance professional with over 25 years of experience, who has been appointed as the Interim CFO. Edwards, a CPA with a strong background in corporate finance, previously held the CFO position at the company and other firms, and will draw a monthly salary of $10,000 plus expenses under a new consulting agreement.
See more insights into BIAF stock on TipRanks’ Stock Analysis page.
